GRC-54276

N/A

Report date: 2022/04/12 14:17:07
NME

Base Information

Drug NameGRC-54276
Drug Alias NameGRC-54276
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase kinase 1 inhibitors
TargetsMitogen-activated protein kinase kinase kinase kinase 1
Therapy Area/IndicationsSolid tumoursHodgkin DiseaseLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlenmark Specialty Sa
China Registration ClassN/A

Develop Information

Active CompaniesGlenmark Specialty Sa
Inactive CompaniesN/A
Active IndicationsSolid tumoursHodgkin DiseaseLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A